Language:   English   |  日本語 (Japanese)

Cambridge, MA, March 19, 2024 — Takeda Hospital Group, a leading healthcare provider in Kyoto, Japan Prefecture, has joined the TriNetX, LLC (TriNetX) network.

Recognizing the need for tailored treatments based on the distinct genetic and lifestyle factors of Japanese patients, Takeda Hospital Group will leverage the TriNetX Network to support clinical research trials.  Jun Takeda, Director of Koseikai Takeda Hospital, expressed enthusiasm about the partnership, stating, “With the constant introduction of new drugs, we expect to highlight the potential risks and benefits of various drug combinations across medical departments by using TriNetX’s large-scale data for research such as age-specific analytical research.”

Shogo Wakabayashi, Japan Country Manager at TriNetX, welcomed Takeda Hospital Group into their network, saying, “We are delighted to welcome the Takeda Hospital Group to the TriNetX Network of healthcare organizations. With our expanding presence in the APAC region and Japan, we are confident in our ability to assist Takeda Hospital Group in achieving their goals.”

Takeda Hospital Group provides a wide range of services in Kyoto Prefecture, including eight advanced medical care hospitals (1,592 beds) ranging from highly acute to chronic care, and more than 70 medical, health checkup, home, nursing care, and welfare programs.

Chairman of the Takeda Hospital Group, Takahisa Takeda, highlighted the significance of the partnership in navigating the complexity of modern medical care. He remarked, “In today’s increasingly intricate medical landscape, collaborating with TriNetX will enable us to visualize clinical data, share knowledge among medical professionals, and benefit patients, healthcare providers, and society by reducing drug loss and lag, particularly for drugs already approved outside of Japan.”


About TriNetX, LLC

TriNetX is a global network of healthcare organizations and life sciences companies driving real-world research to accelerate the development of new therapies. Through its self-service, HIPAA, GDPR, and LGPD-compliant platform of federated EHR, datasets, and consulting partnerships, TriNetX puts the power of real-world data into the hands of its worldwide community to improve protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation. For more information, visit TriNetX at


Media Contact

TriNetX, LLC
Michelle Fleming
+1-857-285-6038 (日本語可)


Media Contact

Takeda Hospital Group



武田病院グループ(本社:京都府京都市、以下「武田病院グループ」)は、このたび、TriNetX, LLC(本社:米国マサチューセッツ州ケンブリッジ、以下「TriNetX社」)が運営する医療機関のネットワークに参加しました。

武田病院グループは、日本人患者特有の遺伝的要因や生活習慣に基づいたオーダーメイド医療の必要性を認識し、TriNetX社のネットワークを活用し、臨床研究や治験を支援していきます。 康生会 武田病院の武田純院長は、「新薬が次々と登場する中、TriNetXの大規模データを活用した年齢別解析などにより、種々の薬剤併用に関する潜在的リスクやベネフィットを診療科横断的に浮き彫りにすることも期待できます」と述べています。





TriNetX, LLC

TriNetXは、新しい治療法の開発を加速するためにリアルワールドデータを用いた研究を推進する医療機関とライフサイエンス企業のグローバルネットワークです。TriNetXは、EHR、データセット、コンサルティングパートナーシップによる連邦型のセルフサービス・プラットフォームであり、HIPAA、GDPR、LGPDに準拠しています。世界中のコミュニティにリアルワールドデータの力を提供し、プロトコルデザインの改善、治験運営の効率化、リアルワールドエビデンスの構築を推進します。詳細については、TriNetXのウェブサイト(をご覧いただくか、X.comで@TriNetX をフォローしてください。



TriNetX, LLC
+1-857-285-6038 (日本語可)







武田病院グループ本部 広報部